Ascendis Pharma A/S (ASND) vs BioNTech SE Sponsored ADR (BNTX)
- Ascendis Pharma A/S ASND 225.78 −0.37%
- BioNTech SE Sponsored ADR BNTX 87.57 −2.92%
Ascendis Pharma A/S and BioNTech SE Sponsored ADR are both Biotechnology companies. BioNTech SE Sponsored ADR is the larger, with a market value of $22.7B against $14.9B — 1.5× the size. BioNTech SE Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Ascendis Pharma A/S trades at 16.3×. Ascendis Pharma A/S grew revenue faster over the last twelve months: 126.0% against −3.33%. Ascendis Pharma A/S has the higher net margin (71.2% vs −65.8%) and the higher return on invested capital (15.1% vs −38.4%). Across the 19 metrics below, Ascendis Pharma A/S leads on 14 and BioNTech SE Sponsored ADR on 5.
Valuation
Profitability
| Metric | ASND | BNTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.26% | 75.24% | 65.16% |
| Operating margin | 24.84% | (77.94%) | 0.00% |
| Net margin | 71.20% | (65.75%) | 0.00% |
| Free cash flow margin | 31.97% | 16.58% | 0.00% |
| Return on equity | 118.44% | (9.53%) | (56.36%) |
| Return on assets | 44.34% | (8.24%) | (48.04%) |
| Return on invested capital | 15.07% | (38.39%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack